View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 29, 2020

UK Government launches platform to fast-track drugs into Covid-19 trials

By Allie Nawrat

The UK Government has launched the Accelerating COVID-19 Research & Development (ACCORD) platform to fast-track potential treatments for Covid-19 through the early stages of clinical trials. If they show promise, they will be fed into large-scale studies, such as the University of Oxford’s RECOVERY trial.

The platform itself is to be provided by IQVIA, and the project is being funded by the Department of Health and Social Care and the UK Research and Innovation (UKRI). It is also supported by expert advice from the National Institute for Health Research (NIHR), as well as academia and industry.

Secretary of State for Health and Social Care Matt Hancock commented: “Currently no drugs in the world have been clinically proven to treat COVID-19. But our Therapeutics Taskforce has identified a number of promising candidates.

“Currently, 6 different treatments have been entered into national clinical trials and the first is ready to enter the next stage: a new early phase clinical trial platform that we are launching today. This is a national effort made possible by government, academia and industry working together.”

The government’s Therapeutics Taskforce will continue to evaluate further therapies to also be included in the project, while industry are able to also suggest other treatments they think should be studied through the platform.

NIHR Covid-19 Research Operations director Dr Jonathan Sheffield said: “ACCORD will transform the way in which the UK’s research community finds treatments for global healthcare challenges such as COVID-19.

“ACCORD is an exemplary case of government, industry and research organisations working together with urgency, to the benefit of patients and the NHS.”

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU